Home / Inspections / 1237404

FDA Inspection 1237404 — Arizona Center for Reproductive Endocrinology & Infertility

Arizona Center for Reproductive Endocrinology & Infertility — FEI 3005391124

The FDA completed an inspection of Arizona Center for Reproductive Endocrinology & Infertility on June 12, 2024 in Tucson, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 12, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tucson, AZ (United States)

Facility

Other inspections at this facility

  • 1209453 (VAI Wed Jun 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1172585 (NAI Wed Jun 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1150646 (NAI Thu Aug 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1014319 (NAI Wed Mar 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 942876 (NAI Wed Sep 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources